Lv51
910 积分 2025-06-23 加入
Cyclin-dependent kinase 4 and 6 inhibitors in breast cancer treatment
10天前
已完结
Discovery of Atirmociclib (PF-07220060): A Potent and Selective CDK4 Inhibitor
11天前
已完结
Bridged Proteolysis Targeting Chimera (PROTAC) Enables Degradation of Undruggable Targets
11天前
已完结
Cyclin D1 and breast cancer
12天前
已完结
The prognostic value of cyclin D1 in breast cancer patients treated with hormonal therapy: A pilot study
12天前
已完结
CDK inhibitors from past to present: A new wave of cancer therapy
17天前
已完结
Recent advance in macrocyclic CDK inhibitors
17天前
已完结
Inavolisib-Based Therapy in PIK3CA -Mutated Advanced Breast Cancer
18天前
已完结
Discovery of GDC-0077 (Inavolisib), a Highly Selective Inhibitor and Degrader of Mutant PI3Kα
18天前
已完结
Targeting the cell-cycle machinery for cancer therapy
22天前
已完结
皖公网安备34019202002308
